Prof. Dr. med. Benjamin Meder
Deputy Medical Director
(Clinic for Cardiology, Angiology and Pneumology)
Head of the Institute
(Institut für Cardiomyopathien Heidelberg)
Head of the Institute
(Herzkatheter)
Research Group Leader
(Molecular Genetics Laboratory)
Medical/Professional background
- since 2017
Managing Senior Physician
- since 2015
Associate Professor (Priv.-Doz.) of Internal Medicine
- since 2014
Senior Physician
- since 2012
Medical Specialist for Internal Medicine and Cardiology
- since 2012
Free journalist (medicine and science)
Scientific background
- since 2011
Head of Genomic Research at the Department of Internal Medicine III, University Hospital of Heidelberg
- since 2009
Research group leader, Laboratory of Molecular Genetics, Department of Internal Medicine III, University Hospital of Heidelberg
- 2005 – 2009
Postdoctoral research fellow in the group for Functional Genomics (Prof. W. Rottbauer), Department of Internal Medicine III, University of Heidelberg
- 2003 – 2004
Scientific Assistant, Laboratory of Engineering & Bioinformatics, Perfusion Technologies GmbH
- 2001 – 2004
Research doctorate, Department of Cardiology, University Hospital of Freiburg
- 1998 – 2005
Medical School, Albert-Ludwigs-University of Freiburg
Commendations
- since 2017
Winterstein Science Award of the German Heart Foundation
- 2009 – 2011
Research fellowship (Young Investigator Award) of the Medical Faculty, University of Heidelberg
- since 2010
Winterstein Science Award of the German Heart Foundation
- 2009
Best Poster Award, 7th Dutch-German Meeting of the Molecular Cardiology Groups
- 2003 – 2005
Scholarship of Bayer Foundations, Leverkusen, Germany
- 2001 – 2005
E-fellows scholarship, Munich, Germany
Professional memberships
- since 2017
Cardiolinc Consortium Member
- since 2016
Fellow of the European Society of Cardiology (FESC;)
- since 2016
Translational Research Committee Member of the Heart Failure Association
- since 2015
Genomics Proteomics Bioinformatics
- since 2014
Editorial Board Member Frontiers Cardiovascular Medicine.
- since 2013
DGK working group 12 “Cardiomyopathies” – Nucleus member
Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V.
DGK working group 8 „Genetik und Molekularbiologie kardiovaskulärer Erkrankungen“
Gut-Glut Heidelberg e.V.
Deutscher Fachjournalisten-Verband (German Association of Specialized Journalists)
Offices and posts held
- 2011 – 2013
Coordinator of the Innovation Alliance “Subgenome Fractionation for High-throughput Sequencing”
- since 2013
Coordinator Cardiomyopathy Group DZHK Registries
- since 2013
Steering committee of the Network for Congenital Heart Diseases
Coordinator Cardiomyopathy Research Board & Institute for Cardiomyopathies Heidelberg (ICH.)
Klinische Ausbildung
- since 2015
DGK qualification Interventional Cardiology
Klinische Spezialität
Kardiomyopathien:
- Dilatative Cardiomyopathie (DCM)
- Linksventrikuläre Noncompaction-Cardiomyopathie (LVNC)
- Arrhytmogene Rechtsventrikuläre Cardiomyopathie (ARVC)
- Tako Tsubo Syndrom
Klinische Schwerpunkte
Interventionelle Kardiologie
Kardiomyopathien
Experimentelle Schwerpunkte
Genetik und Epigenetik von Kardiomyopathien
Translationale Biotechnologie
Omics-basierte Biomarker
Funding
- 2022 – 2027
Cardiac Splicing as a Therapeutic Target (CASTT) (Leducq Foundation)
- 2022 – 2027
Sonderforschungsbereich CRC1550 (Deutsche Forschungsgemeinschaft – DFG)
- 2022 – 2023
Kausale Modellierung und adaptives experimentelles Design für Einzelzell-Perturbations-Experimente ((Deutsche Forschungsgemeinschaft – DFG)
- 2022 – 2024
AI Health Innovation Cluster Heidelberg (MWK Baden-Württemberg)
- 2019 – 2027
Translational Registry for Cardiomyopathies TORCH-Plus (DZHK BMBF)
- since 2019
CARDIATEAM within innovative medicines initiative (IMI, EU and EFPIA)
- 2019 – 2024
ActiveDCM interventional Trial (Deutsche Herzstiftung und Apple Inc.)
- 2019 – 2022
Regulation of myosin-light chains (DFG)
- 2018 – 2024
Informatics for Life (Klaus-Tschira Stiftung)
- 2018 – 2022
Hereditary sick sinus syndrome – phenotypic spectrum, genetic basis, cellular dysfunction and implications for therapy (Deutsche Forschungsgemeinschaft – DFG)
- 2018 – 2021
Else Kröner-Exzellenz-Stipendium
- 2018 – 2021
HIGHmed (BMBF)
- 2018 – 2020
Leben mit Kardiomyopathie (Deutsche Herzstiftung)
- 2017 – 2020
Promise (BMBF) ERA-CVD Detectin-HF (EU, BMBF).
- 2016 – 2019
Promise (BMBF) ERA-CVD Detectin-HF (EU, BMBF 2017-2020).
- 2016 – 2019
eMed Systems Biology CaRNAtion (BMBF)
- 2014 – 2019
Klaus Tschira Foundation
- 2013 – 2017
BestAgeing (EU FP7)
- 2012 – 2014
“Translational Biotechnology” (Siemens AG)
- 2011 – 2013
Innovationsfond FRONTIER “Development of miRNA-based biomarkers” (University of Heidelberg)
- 2010 – 2013
INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);
- 2009 – 2013
INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);
- 2008 – 2013
NGFN Plus project “DNA and Mutation-Screening Platform” (BMBF)
- since 2012
German Center for Cardiovascular Research – DZHK (BMBF)
- 2008 – 2012
NGFN Transfer project “Targeted Next-Generation Sequencing” (BMBF)
- 2009 – 2010
Start-up of an Excellence Cluster: “Heart and Cancer” (MWK)
- 2014 – 2018
Translational Registry for Cardiomyopathies TORCH (DZHK BMBF)
Patents Applications
US 61/326,043 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 10 004 190.4 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
US 13/642,321 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 11715666.1 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
PCT/EP2011/001999 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 101 851 36.8 Complex miRNS sets as novel biomarkers for an acute coronary syndrome;
EP 11169192.9 MicroRNA signatures als Biomarker für die dilatative Kardiomypathie (DCM) und Herzinsuffizienz; PCT/EP2012/060927 Complex set of miRNAs as noninvasive biomarkers for dilated cardiomyopathy;
13 709 132.8 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;
PCT/EP2013/055267 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;
EP12163180.8 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;
PCT/EP2013/057118 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;
EP 13168684.2 MICRORNA as non-invasive biomarkers for heart failure